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In Cambodia, 1,303 bats of 16 species were tested for
lyssavirus. No lyssavirus nucleocapsid was detected in
1,283 brains tested by immunofluorescence assay.
Antibodies against lyssaviruses were detected by enzyme-
linked immunosorbent assay in 144 (14.7%) of 981 serum
samples. Thirty of 187 serum samples contained neutraliz-
ing antibodies against different lyssaviruses.
T
he genus Lyssavirus belongs to the family
Rhabdoviridae and includes seven species and one
tentative species (1). Six of these seven species (or geno-
types) have been isolated from bats. Rabies virus (RABV),
responsible for most human rabies cases in the world, is
associated with bats only in the Americas, and this associ-
ation is currently responsible for most human rabies cases
in North America. Lagos bat virus (LBV) and Duvenhage
virus (DUVV) are found in Africa. European bat
lyssavirus-1 (EBLV-1) and European bat lyssavirus-2
(EBLV-2) have been isolated in Europe. Australian bat
lyssavirus (ABLV) has been detected in Australia. DUVV,
EBLV-1, EBLV-2, and ABLV have been responsible for
several fatal cases in humans (2–4).
In Asia, rabies infection of bats has rarely been report-
ed. Ahuman case of rabies with history of bat bite was first
reported in 1954 in southern India. Two large surveys in
the Philippines and in Malaysia failed to detect any rabid
bats. Lyssavirus infection was detected in Thailand in a
frugivorous bat, Cynopterus brachyotis, and in India in a
frugivorous bat, Pteropus poliocephalus (2). Recently, new
lyssaviruses (Aravan, Khujand, Irkut, and West Caucasian
bat viruses) were isolated in southern Kyrghyzstan, north-
ern Tajikistan, eastern Siberia, and the Caucasus from
Myotis blythi,  M. mystacinus,  Murina leucogaster, and
Miniopterus schreibersi, respectively (5). Furthermore,
neutralizing antibodies against ABLV were detected in the
Philippines in two frugivorous species and four insectivo-
rous species, notably M. schreibersi (6).
In Cambodia, rabies is endemic, transmitted mainly by
dogs. Since 1997, the Institut Pasteur du Cambodge (IPC)
has received heads of suspected rabid domestic dogs from
11 of the 23 Cambodian provinces. Dogs from nine
provinces had laboratory-confirmed rabies infection. Since
mid-1995, ≈9,000 people per year have received free post-
exposure rabies treatment at IPC. No case of a human with
rabies and a history of bat bite has ever been reported to
IPC (7), but potential exposure to rabies from bats is often
underappreciated (8).
Surveillance for lyssaviruses in bats in Southeast Asia
has been very limited to date. No isolate has been identi-
fied, and no particular bat species has been implicated as a
potential reservoir. We therefore conducted a survey to
look for lyssavirus infection among bat populations in
Cambodia.
The Study
Atotal of 1,303 bats were sampled from 35 locations in
nine Cambodian provinces (Figure). Of these, 467 came
from restaurants in Phnom Penh and belonged to the
species P. lylei. The other 836 animals were captured in
nine provinces and belonged to 16 species representing six
of the seven bat families known in Cambodia (Table 1,
Figure). Bats were captured at roosts by hand and with
hand nets, or along flyways by night with mist nets or hard
traps. Anesthetized captured animals were euthanized by
cardiac blood puncture, and their organs were collected.
Sampling bats from restaurants was restricted to collecting
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Figure. Location of bat capture sites during a survey on lyssavirus
infection in bats in Cambodia, September 2000–May 2001.blood and brain. All bats specimens were stored in 70%
ethanol until species was identified.
Direct immunofluorescence assay (IFA) was performed
on the brain of 1,283 (20 were not testable) bats to detect
lyssavirus nucleocapsid (9). Rabbit antirabies nucleocap-
sid immunoglobulin G (Bio-Rad, Marnes-la-Coquette,
France) was used at a concentration (2x) that reliably
detects infection with the seven lyssavirus genotypes.
None of the brains tested was positive. Attempts to isolate
virus in newborn mice (9) from the brains of 24 bats that
gave uncertain IFA results were unsuccessful.
Serum samples of bats were first screened for antibod-
ies against lyssavirus by enzyme-linked immunosorbent
assay (ELISA). Antigens were obtained from inactivated
and titrated supernatants of BHK21 clone BSR cell cul-
tures infected independently by four different genotypes
circulating in bats, RABV (CVS strain), LBV, ABLV, and
EBLV-1. These strains were chosen according to their abil-
ity to detect cross-neutralizing antibodies (10). Each super-
natant was diluted to a titer of 6 x 104 focus-forming units
(FFU)/mL in carbonate buffer. Polysorp 96-well plates
(Nunc, Roskilde, Denmark) were coated with 100 µLo f
RABV (CVS)/LBV mixture and 100 µL of ABLV/EBLV-
1 mixture and incubated at 4°C overnight. The samples
were diluted 1:50. Peroxidase-labeled protein A/G (Pierce,
Rockford, IL) was used as conjugate. Three negative con-
trol serum samples and one positive control sample
(equine rabies immunoglobulin 200 IU/mL) diluted 1:50
were included in each plate. Washing and diluent buffers,
incubation, cutoff value, and positive definitions followed
Rossi and Ksiazeck’s technique (11). Of the 981 bat serum
samples tested by this ELISA, 144 (14.7%) had a positive
result (Table 1). Animals with ELISA-positive samples
belonged to eight different species of both frugivorous and
insectivorous bats.
ELISA test results were confirmed by using lyssavirus
rapid fluorescent focus inhibition test (RFFIT) on 144
ELISA-positive and 43 ELISA-negative samples chosen at
random. Each sample was tested independently against
four different lyssaviruses: RABV, EBLV-1, ABLV, and
LBV by an adaptation of RRFIT (12) and was considered
positive for an average titer >42 after two independent
assays. 
Of the 146 samples with interpretable RFFIT results
(76% were ELISA-positive), 10 (31%) of 32 samples from
frugivorous bats and 20 (18%) of 114 samples from insec-
tivorous bats were positive for neutralizing antibodies
against at least one of the four genotypes (Table 2). In
some cases when high titers against one virus were record-
ed, cross-neutralization occurred with other viruses.
Geometric means for the 30 positive responses were 76.2
(n = 6), 71.9 (n = 13), 97.4 (n = 12), and 83.8 (n = 7)
against CVS, EBLV-1, ABLV, and LBV, respectively.
Eleven samples exhibited titers >100. Among the 10
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against ABLV were the most frequent (50%). Conversely,
neutralizing antibodies against EBLV-1 were the most fre-
quent (50%) among the 20 RFFIT-positive insectivorous
bats. Positive responses were in the majority (83.3%)
against these two viruses. The 30 bats with neutralizing
antibodies belonged to frugivorous species, Cynopterus
sphinx (n = 3) and P. lylei (n = 7), or insectivorous species,
Hipposideros larvatus (n = 2), Scotophilus kuhlii (n = 5),
Taphozous theobaldi (n = 2), T. melanopogon (n = 1), and
Tadarida plicata (n = 10). No meaningful geographic
trends were identified.
Conclusions
This study reports the first evidence of anti-lyssavirus
neutralizing antibodies in serum samples from insectivo-
rous and frugivorous bats in Cambodia. These serologic
data support the likely occurrence of rabies, possibly from
a previously undescribed lyssavirus, among bats in
Cambodia.
A simple ELISA was developed to detect antibodies
against lyssavirus in bat serum samples as a first screening.
The sensitivity and specificity of this test can be estimated
by comparing its results with those of the RFFIT, which is
considered the most effective and reliable method of
detecting anti-lyssavirus antibodies. This comparison
gives us a relatively high sensitivity (83%, n = 30) and a
low specificity (27%, n = 116); therefore, ELISA could be
used to test large numbers of samples. RFFIT, a time-con-
suming technique, could be used to double-check ELISA-
positive samples. However, prevalence results obtained
with ELISA should be considered cautiously because
RFFIT was performed on samples selected according to
ELISA results (and not performed simultaneously with
ELISA on randomly chosen samples).
The threshold for RFFIT positivity chosen in this study
was slightly higher than that used in recent bat studies per-
formed in Europe (3) and the Philippines (6). Although no
accepted standard for bat sera exists, the titer of 42
obtained in RFFIT against CVS-11 corresponds in our
hands to a titer of 0.8 IU/mL using the World Health
Organization (WHO) human standard. The arbitrary cutoff
chosen during this study is then slightly higher than the
arbitrary value (0.5 IU/mL) established by WHO as evi-
dence of neutralizing antibodies against rabies having been
induced after vaccination (13). This cutoff was chosen to
avoid problems of test specificity because of hemolysis
present in some specimens. The samples considered to be
positive in this study should then be considered as highly
indicative of anti-lyssavirus–specific antibodies.
None of the brain samples showed evidence of
lyssavirus antigen or infectious particles. Similar studies
did not succeed in detecting lyssavirus antigen or RNA in
bats (3,6,14,15). Because the 1,303 bats collected in
Cambodia during this study were healthy and belonged to
16 different species, the expected number of positive reac-
tions would not be very high. One positive bat among them
would indicate a global prevalence of active infection of 8
per 104 bats, which would be high for randomly selected
healthy bats.
Further investigation is needed to determine whether
the circulation of lyssavirus in the Cambodian bat popula-
tion poses a threat to human health. In the meantime, pos-
texposure treatment should be considered in the event of a
bat bite. The public, especially persons in close contact
with bats (guano collectors, sugar palm tree collectors, per-
sons with bats roosting in their houses), should be educat-
ed about the risk for rabies transmission from bats and
should be encouraged to participate in surveillance by
shipping specimens from sick bats for laboratory diagnosis
of rabies.
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